Key result
Advanced carotid atherosclerosis is linked to ~40-fold higher risk of cancer and CV death.
Why the study?
It was investigated whether there is a relationship between advanced atherosclerosis of the carotid artery and cancer.
Does statin treatment reduce death from cancer and cardiovascular disease in men with advanced atherosclerosis of the carotid artery?
Observational (n=2,143)
Does statin treatment reduce death from cancer and cardiovascular disease in men with advanced atherosclerosis of the carotid artery?
Hazard Ratio: 39.82 (95% CI 9.17–172.91)
Absolute Event Rate: 5.3% vs 0%
p-value: p=<0.0001
Statin treatment is associated with a lower rate of cancer and cardiovascular death in men with advanced carotid atherosclerosis.
Statin use may lower events in advanced carotid atherosclerosis; leaves open confirmation by randomized trials before practice change.
Background and aims: It was investigated whether there is a relationship between advanced atherosclerosis of the carotid artery and cancer. Method: The carotid Total Plaque Area (TPA), the maximum plaque thickness, and the cardiovascular risk based on Framingham calculator using body-mass-index were determined in healthy subjects using ultrasound. We compared the outcome in subjects with advanced atherosclerosis of the carotid artery (type III-IV b finding) with and without statin treatment. The follow-up was collected as part of occupational health check-ups. Result: In 4207 healthy men aged 35-65 years (50±8 years) we found 578 subjects with advanced atherosclerosis of the carotid artery (type III-IV b finding). A follow-up was available for 566 (97.9%) subjects. The average follow-up time was 48 months (range 0 to 139 months). Ten subjects were excluded because of missing data on treatment. A total number of 230 subjects was treated with a statin, 326 received no statin. Within the group of these subjects (54±6 years), 33 men died (15 cancer, 4 strokes, 11 heart attacks, 1 COPD, 1 sepsis, 1 cirrhosis of the liver). In the group with CVD death, two subjects were treated with a statin, 13 were untreated. In the group with cancer death, two subjects were treated with a statin, 13 were untreated. The death rate because of cancer and CVD was 1.7% for the treated subjects and 8.0% for the untreated subjects. In the group with low risk (n= 1890), six men died (2 traffic accidents, 1aneurysm bleeding, 2 cancer, 1 unclear, a follow-up examination has been completed for 43.9% (n= 830) of the subjects, mean follow-up time of 65 months (0-137 months). One man died (Parkinson) within the group with intermediate risk. In this group (n= 482) a follow-up examination has been completed for 55% (n= 265) with a mean follow-up time of 55 months (total range: 0-130 months). In the reference group (no atherosclerosis; n= 1257) follow-up has been completed in 38.3% (n= 482) with a mean follow-up time of 60 (0-145) months and nobody died. In 3203 healthy women aged 35-65 years nobody died of cancer. Conclusion: The development of cancer in men with advanced atherosclerosis of the carotid artery appears to be noticeable. The question of whether there is a causal relationship requires further investigations.
No takes yet. Share an insight, caveat, or question.
Adams et al. (2022) conducted an observational in Healthy subjects (occupational health check-ups) (n=2,143). Advanced carotid atherosclerosis (Type III-IV b) vs. No or low carotid atherosclerosis was evaluated on Cancer and cardiovascular death (HR 39.82, 95% CI 9.17-172.91, p=<0.0001). Advanced carotid atherosclerosis was significantly associated with an increased risk of cancer and cardiovascular death compared to no atherosclerosis (HR 39.82).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: